12999 related articles for article (PubMed ID: 10590384)
1. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
3. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis.
Miettinen M; Fetsch JF
Hum Pathol; 2000 Sep; 31(9):1062-7. PubMed ID: 11014572
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
5. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
Tokuyama W; Mikami T; Masuzawa M; Okayasu I
Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.
Jussila L; Valtola R; Partanen TA; Salven P; Heikkilä P; Matikainen MT; Renkonen R; Kaipainen A; Detmar M; Tschachler E; Alitalo R; Alitalo K
Cancer Res; 1998 Apr; 58(8):1599-604. PubMed ID: 9563467
[TBL] [Abstract][Full Text] [Related]
7. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.
Li R; Younes M; Wheeler TM; Scardino P; Ohori M; Frolov A; Ayala G
Prostate; 2004 Feb; 58(2):193-9. PubMed ID: 14716745
[TBL] [Abstract][Full Text] [Related]
9. Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues.
Remotti F; Fetsch JF; Miettinen M
Hum Pathol; 2001 Aug; 32(8):873-9. PubMed ID: 11521233
[TBL] [Abstract][Full Text] [Related]
10. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
Fukunaga M
Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
[TBL] [Abstract][Full Text] [Related]
12. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.
Miettinen M; Sarlomo-Rikala M; Lasota J
Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925
[TBL] [Abstract][Full Text] [Related]
13. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
Clarijs R; Schalkwijk L; Hofmann UB; Ruiter DJ; de Waal RM
Cancer Res; 2002 Dec; 62(23):7059-65. PubMed ID: 12460927
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S
J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
[TBL] [Abstract][Full Text] [Related]
16. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
18. Angiostatin receptor annexin II in vascular tumors including angiosarcoma.
Syed SP; Martin AM; Haupt HM; Arenas-Elliot CP; Brooks JJ
Hum Pathol; 2007 Mar; 38(3):508-13. PubMed ID: 17239928
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
Wilting J; Papoutsi M; Christ B; Nicolaides KH; von Kaisenberg CS; Borges J; Stark GB; Alitalo K; Tomarev SI; Niemeyer C; Rössler J
FASEB J; 2002 Aug; 16(10):1271-3. PubMed ID: 12060670
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E
Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]